SG Trading Solutions LLC purchased a new stake in Danaher Corporation (NYSE:DHR – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 2,860 shares of the conglomerate’s stock, valued at approximately $655,000.
A number of other institutional investors have also recently bought and sold shares of the company. Enterprise Financial Services Corp raised its holdings in Danaher by 1.4% in the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after purchasing an additional 46 shares during the period. Kennebec Savings Bank increased its position in shares of Danaher by 1.4% in the 4th quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock valued at $766,000 after buying an additional 46 shares in the last quarter. Revolve Wealth Partners LLC increased its position in shares of Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after buying an additional 47 shares in the last quarter. High Note Wealth LLC raised its stake in Danaher by 19.2% during the 4th quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the period. Finally, First Command Advisory Services Inc. raised its stake in Danaher by 4.4% during the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock worth $253,000 after buying an additional 47 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Stock Up 0.3%
DHR stock opened at $177.74 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a market capitalization of $125.80 billion, a P/E ratio of 34.38, a P/E/G ratio of 2.26 and a beta of 0.81. The business has a 50-day moving average of $179.62 and a 200-day moving average of $203.07. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is currently 30.95%.
Analyst Upgrades and Downgrades
DHR has been the subject of several recent analyst reports. Morgan Stanley lowered their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Barclays decreased their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Finally, The Goldman Sachs Group cut their price target on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $233.61.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Aehr Spikes on New Order, But Has Stock Gotten Ahead of Itself?
- Rackspace’s AI Land Grab: Plugging Into the Next Compute Boom
- Satellogic Is Tiny But Its Revenue Growth Is Hard to Ignore
- Why Kroger’s Pullback Could Be a Gift for Patient Investors
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
